healthcare
Legend leads $29m round for Chinese biotech player
Sciwind Biosciences, a Chinese drug developer focused on treating metabolic disorders, has raised RMB200 million ($29 million) in Series A funding led by Legend Capital, with participation from existing investors Shiyu Capital and Beijing-based biotech...
Intudo closes second Indonesia fund at $50m
Intudo Ventures has closed its second fund focused exclusively on Indonesian early-stage companies at $50 million. The firm raised $20 million for its debut vehicle last year.
Vision Knight backs Chinese personal care products maker
Vision Knight Capital has led a RMB200 million ($29 million) Series C round for Soocas, a Shenzhen-based manufacturer of personal care products such as electric toothbrushes and hairdryers.
Huagai leads $146m round for China’s HaiHe Biopharma
Shanghai-based cancer drug developer HaiHe Biopharma has raised $146.6 million in a funding round led by Chinese private equity firm Huagai Capital.
HighLight reaches first close on third renminbi vehicle
Chinese healthcare-focused GP HighLight Capital, which was set up by Steven Wang, formerly of CDH Investments, has reached the first close for its third renminbi vehicle at around 70% of the hard cap.
Ascent Capital launches Myanmar PE fund
Ascent Capital, a Singapore-based private equity firm set up last year with a focus on Myanmar, has formally launched its debut fund with about $50 million in confirmed commitments.
Suning invests in Yunfeng co-invest vehicle for iKang take-private
Chinese consumer electronics retailer Suning has committed $50 million to a US dollar-denominated co-investment vehicle managed by Yunfeng Capital that will support the $1.4 billion privatization of iKang Healthcare Group.
Fund focus: Sizing up selectively
ChrysCapital Partners has increased its fund size and its commitment to operations in response to a maturation of the Indian market characterized by bigger deals and more opportunities to drive change
Chinese eye hospital chain Chaoju raises $59m
Chinese eye hospital chain operator Chaoju Ophthalmology has raised RMB400 million ($59 million) in a Series B round of funding backed by Orchid Asia Group and River Head Capital.
Chinese cancer database provider Medbanks raises $59m
Beijing and Shanghai-based Medbanks, an information service provider specializing in cancer care, has raised RMB400 million ($59 million) in Series C funding led by CLP Fund.
China’s Zhiyun Health nets $100m Series C round
Chinese online healthcare services provider Zhiyun Health has raised $100 million in a Series C round of funding across two tranches.
China's Miaoshou Doctor raises $72.8m
China-based healthcare care services provider Miaoshou Doctor has raised RMB500 million ($72.8 million) in an extended Series C round of funding led by Starquest Capital, with participation from Sequoia Capital China.
Malaysia's Ekuinas launches fourth fund at $242m
Malaysian government-backed private equity firm Ekuinas has set up its fourth fund with MYR1 billion ($242 million) and an option to increase the corpus to MYR1.5 billion.
China drug trading platform Yaoshibang raises $133m Series D
Chinese B2B pharmaceutical trading and education platform Yaoshibang has raised $133 million in a Series D round of funding led by Tiger Global Management, H Capital, and DCM.
PE-backed WuXi Apptech trades flat on Hong Kong debut
PE-backed WuXi AppTec, a contract pharmaceutical R&D services provider, traded flat on its Hong Kong debut, following an IPO of HK$9.1 billion ($1.1) billion.
China's WuXi NextCode closes $200m Series C
WuXi NextCode, a genome sequencing analysis business with ties to China-based contract research organization WuXi PharmaTech, has raised $200 million in a Series C round of funding from a consortium led by the Ireland Strategic Investment Fund (ISIF).
Cocoon launches $20m Southeast Asia VC fund
Singapore-based VC investor Cocoon Capital has launched its second early-stage fund with a target of $20 million.
MassMutual sets up $50m Southeast Asia VC fund
US-based Massachusetts Mutual Life Insurance Company (MassMutual) has established a $50 million Southeast Asia-focused VC fund via its in-house financial technology investment unit.
Innovent Biologics gains on debut after $421m IPO
Chinese cancer drug developer Innovent Biologics, which has a number of PE backers, closed up on its Hong Kong trading debut, following a HK$3.3 billion ($421 million) IPO.
Deal focus: Meltin plans next stage in human evolution
Japanese bio-robotics start-up Meltin has received a $17.7 million Series B round from a group of investors including SBI Investment with a view to revolutionizing human-machine interfaces
India's IvyCap launches $8m angel fund
India’s IvyCap Ventures has launched an angel fund targeting INR600 million ($8.2 million) that will make seed to Series A-stage investments.
Bain seeks $3.5b for fourth Asia fund
Bain Capital Private Equity has set a target of $3.5 billion for its fourth Asia fund and is expected to complete a first and final close in December.
India healthcare: The growth infusion
Indian hospitals are increasingly attractive for private equity investors. GPs can thrive in the space with a well-defined growth strategy that takes local market requirements into account
Cathay reaches $700m first close on Sino-European fund
Cathay Capital Private Equity has reached a first close of EUR600 million ($702 million) for its latest middle-market Sino-European fund. The target is EUR1.2 billion.